Inhibition of P450 aromatase enhances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E
- PMID: 11600558
- DOI: 10.1210/jcem.86.10.7927
Inhibition of P450 aromatase enhances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E
Abstract
In early pubertal boys, E concentrations are very low. We studied the role and site of action of endogenous E in the regulation of gonadotropin secretion in early and midpubertal boys by inhibiting the action of E with a potent and specific P450 aromatase inhibitor, letrozole. A total of 35 boys who were referred to us because of suspicion of delayed puberty were included in the study. The boys were in either early or midpuberty, and they composed 3 groups: 10 boys did not receive any treatment, 12 boys received T alone, and 13 boys received T and letrozole. In the untreated group during the 5-month follow-up, no changes were observed in 17beta-E2, T, basal gonadotropin, or inhibin B concentrations or in the GnRH-induced gonadotropin responses. In the T-treated group during the 5-month treatment, the T concentration increased by 55% (P < 0.05), and the 17beta-E2 concentration increased by 130% (P < 0.02). Concurrently, basal gonadotropin concentrations were suppressed, but the GnRH-induced gonadotropin responses and the inhibin B concentration remained unchanged. In the T- plus letrozole-treated group during the 5-month treatment, an increase in T concentration of 606% was observed (P < 0.001), but the 17beta-E2 concentration remained unchanged. The changes in the 17beta-E2 concentration within 5 months in the untreated and the T- plus letrozole-treated groups were different (P < 0.02), indicating significant inhibition of endogenous E synthesis during letrozole treatment. During the T plus letrozole treatment, basal gonadotropin concentration, the GnRH-induced LH response, and inhibin B concentration increased, and the GnRH-induced FSH response did not change significantly. Serum nocturnal gonadotropin pulses were determined in 5 boys treated with T and in 5 boys treated with T plus letrozole. In the T- plus letrozole-treated group, the nocturnal LH pulse amplitude increased, and the LH pulse frequency and interpulse interval remained unchanged. In conclusion, in early and midpubertal boys, suppression of the action of E by the P450 aromatase inhibitor increased LH concentration, LH pulse amplitude, and the GnRH-induced LH response, which indicates that in boys during early and midpuberty, endogenous E regulates LH secretion at the site of the pituitary.
Similar articles
-
Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.J Clin Endocrinol Metab. 2003 Aug;88(8):3785-93. doi: 10.1210/jc.2002-021643. J Clin Endocrinol Metab. 2003. PMID: 12915670 Clinical Trial.
-
Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion.J Clin Endocrinol Metab. 2001 Jan;86(1):53-8. doi: 10.1210/jcem.86.1.7101. J Clin Endocrinol Metab. 2001. PMID: 11231978
-
Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback.J Clin Endocrinol Metab. 2000 Sep;85(9):3027-35. doi: 10.1210/jcem.85.9.6795. J Clin Endocrinol Metab. 2000. PMID: 10999781 Clinical Trial.
-
The dawning of the non-cancer uses of aromatase inhibitors in gynaecology.Hum Reprod. 2003 Aug;18(8):1598-602. doi: 10.1093/humrep/deg310. Hum Reprod. 2003. PMID: 12871868 Review. No abstract available.
-
Aromatase inhibitors with or without luteinizing hormone-releasing hormone agonist for metastatic male breast cancer: report of four cases and review of the literature.Breast Cancer. 2016 Nov;23(6):945-949. doi: 10.1007/s12282-016-0679-2. Epub 2016 Feb 15. Breast Cancer. 2016. PMID: 26879549 Review.
Cited by
-
Letrozole Monotherapy in Pre- and Early-Pubertal Boys Does Not Increase Adult Height.Front Endocrinol (Lausanne). 2019 Apr 5;10:201. doi: 10.3389/fendo.2019.00201. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31024444 Free PMC article.
-
Aromatase inhibitors: a useful additional therapeutic option for slowing down advanced bone age in boys with growth hormone deficiency.J Endocrinol Invest. 2024 May;47(5):1227-1235. doi: 10.1007/s40618-023-02242-w. Epub 2023 Dec 1. J Endocrinol Invest. 2024. PMID: 38040920
-
Aromatase inhibitors in pediatrics.Nat Rev Endocrinol. 2011 Oct 25;8(3):135-47. doi: 10.1038/nrendo.2011.161. Nat Rev Endocrinol. 2011. PMID: 22024975 Review.
-
Localization of the aromatase enzyme expression in the human pituitary gland and its effect on growth hormone, prolactin, and thyroid stimulating hormone axis.Endocrine. 2015 Aug;49(3):761-8. doi: 10.1007/s12020-015-0537-6. Epub 2015 Feb 20. Endocrine. 2015. PMID: 25697985
-
GnRH receptor gene mutations in adolescents and young adults presenting with signs of partial gonadotropin deficiency.PLoS One. 2017 Nov 28;12(11):e0188750. doi: 10.1371/journal.pone.0188750. eCollection 2017. PLoS One. 2017. PMID: 29182666 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical